Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients
- PMID: 17703910
- PMCID: PMC2732111
- DOI: 10.1016/j.jpainsymman.2007.01.016
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients
Abstract
Assessment of patient quality of life (QOL) requires balancing the details provided by multi-item assessments with the reduced burden of single-item assessments. In this project, we investigated the psychometric properties of single-item Linear Analog Scale Assessments (LASAs) for patients with newly diagnosed high-grade gliomas. Measures included QOL LASAs (overall, physical, emotional, spiritual, intellectual), Symptom Distress Scale (SDS), Profile of Mood States (POMS; overall, confusion, fatigue), and Functional Assessment of Cancer Therapy-Brain (FACT-Br; overall, brain, physical, emotional). Associations of LASA measures with SDS, POMS, and FACT-Br domains and with Eastern Cooperative Oncology Group performance score (PS) and Mini-Mental State Examination (MMSE) were assessed. Repeated measures ANOVA models compared the change over time of LASAs and SDS, POMS, and FACT-Br. Two hundred five patients completed the assessments across three time points. To allow comparison across measures, all scores were converted to a scale of 0-100, with higher scores indicating better QOL. LASA mean scores ranged from 60 to 78; SDS, POMS, and FACT-Br ranged from 62 to 81. FACT-Br physical (P<0.001) and POMS fatigue subscale (P=0.005) decreased over time, as did LASA physical (P=0.08). LASA scales were strongly associated with corresponding scales on SDS, POMS, and FACT-Br (0.44<rho<0.65; P<0.001). LASA was negatively associated with PS and positively with MMSE, with associations similar in magnitude to the other QOL and psychosocial measures. The data suggest that the single-item LASA scales are valid for assessing QOL of cancer patients and are an appropriate alternative when a shorter instrument is warranted.
Conflict of interest statement
The authors have no conflict of interest or financial involvement with this manuscript.
Similar articles
-
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.J Neurooncol. 2006 Feb;76(3):283-91. doi: 10.1007/s11060-005-7020-9. J Neurooncol. 2006. PMID: 16163448
-
Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?Support Care Cancer. 2013 Sep;21(9):2485-90. doi: 10.1007/s00520-013-1825-4. Epub 2013 Apr 23. Support Care Cancer. 2013. PMID: 23609927 Clinical Trial.
-
Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.J Neurooncol. 2014 Dec;120(3):499-506. doi: 10.1007/s11060-014-1574-3. Epub 2014 Aug 13. J Neurooncol. 2014. PMID: 25115739 Free PMC article.
-
FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review.Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):701-8. doi: 10.1586/erp.11.67. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 22098286 Review.
-
Cognitive functioning and quality of life in malignant glioma patients: a review of the literature.Psychooncology. 1997 Sep;6(3):169-77. doi: 10.1002/(SICI)1099-1611(199709)6:3<169::AID-PON269>3.0.CO;2-#. Psychooncology. 1997. PMID: 9313282 Review.
Cited by
-
Psychological interventions to foster resilience in healthcare professionals.Cochrane Database Syst Rev. 2020 Jul 5;7(7):CD012527. doi: 10.1002/14651858.CD012527.pub2. Cochrane Database Syst Rev. 2020. PMID: 32627860 Free PMC article.
-
Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients.Int J Public Health. 2023 Aug 30;68:1605459. doi: 10.3389/ijph.2023.1605459. eCollection 2023. Int J Public Health. 2023. PMID: 37711159 Free PMC article. Clinical Trial.
-
Measuring symptoms and toxicities: a 35-year experience.Support Care Cancer. 2023 Jul 27;31(8):495. doi: 10.1007/s00520-023-07958-2. Support Care Cancer. 2023. PMID: 37498410 Review.
-
Exploring primary brain tumor patient and caregiver needs and preferences in brief educational and support opportunities.Support Care Cancer. 2015 Mar;23(3):851-9. doi: 10.1007/s00520-014-2413-y. Epub 2014 Sep 14. Support Care Cancer. 2015. PMID: 25218608
-
Patient-Reported Physical Function Measures in Cancer Clinical Trials.Epidemiol Rev. 2017 Jan 1;39(1):59-70. doi: 10.1093/epirev/mxx008. Epidemiol Rev. 2017. PMID: 28453627 Free PMC article.
References
-
- Sloan J, Frost M, Berzon R, et al. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer. 2006;14(10):988–998. - PubMed
-
- Rummans T, Bostwick M, Clark M. Maintaining quality of life at the end of life. Mayo Clin Proc. 2000;75:1305–1310. - PubMed
-
- Cella D. Methods and problems in measuring quality of life. Support Care Cancer. 1995;3:11–22. - PubMed
-
- Cheung Y, Goh C, Thumboo J, et al. Variability and sample size requirements of quality of life measures: a randomized study of three major questionnaires. J Clin Oncol. 2005;23:4936–4944. - PubMed
-
- Osoba D. A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Med Care. 2002;40(6 Suppl):III31–III38. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical